FDA Drug recall D-0332-2026
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt
- FDA Drug
- Class I
- ongoing
- Published 2026-02-11
On 2026-02-11 the FDA classified a Class I recall of Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt by Handelnine Global, citing CGMP Deviations: product found to contain lead.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0332-2026 |
| Classification | Class I |
| Status | ongoing |
| Initiated | 2025-12-22 |
| Published | 2026-02-11 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Handelnine Global |
| Distribution | NY |
Product
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
Reason
CGMP Deviations: product found to contain lead.
Identifiers
| upc | 8904218700313 |
|---|---|
| code_info | Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0332-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.